Literature DB >> 18023442

Risk factors for deep endometriosis: a comparison with pelvic and ovarian endometriosis.

Fabio Parazzini1, Sonia Cipriani, Stefano Bianchi, Francesca Gotsch, Giovanni Zanconato, Luigi Fedele.   

Abstract

OBJECTIVE: To assess whether deep endometriosis has different risk factors compared with endometriosis at other sites. In epidemiological terms, this should be the case if deep endometriosis represents a different condition than ovarian and peritoneal endometriosis.
DESIGN: Case-control study.
SETTING: University hospitals. PATIENT(S): The first group of cases included 181 women with a diagnosis of deep endometriosis. The second group of cases included 162 women with endometriosis at other sites. The control group included women younger than 55 years of age who were admitted for acute non-gynecological, non-hormonal, non-neoplastic conditions. INTERVENTION(S): Questionnaire. MAIN OUTCOME MEASURE(S): Odds ratios. RESULT(S): The age distribution of women with cases of deep and ovarian and pelvic endometriosis was not statistically significantly different. A higher body mass index decreased the risk of both deep as well as ovarian and pelvic endometriosis: the estimated ORs for women reporting a body mass index of > or =21 vs. those reporting a body mass index of <21 were 0.6 (95% confidence interval [CI], 0.3-0.8) for deep endometriosis and 0.6 (95% CI, 0.4-0.9) for pelvic and ovarian endometriosis. Parous women were at decreased risk: in comparison with nulliparae, the odds ratio for deep endometriosis was 0.1 (95% CI, 0.1-0.2) for women reporting one or more births. The corresponding value for pelvic and ovarian endometriosis was 0.1 (95% CI, 0.1-0.2). CONCLUSION(S): This study suggests that deep as well as ovarian and pelvic endometriosis share similar risk factors.

Entities:  

Mesh:

Year:  2007        PMID: 18023442     DOI: 10.1016/j.fertnstert.2007.05.059

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

1.  Adiposity and Endometriosis Severity and Typology.

Authors:  Jiyoung Byun; C Matthew Peterson; Uba Backonja; Robert N Taylor; Joseph B Stanford; Kristina L Allen-Brady; Ken R Smith; Germaine M Buck Louis; Karen C Schliep
Journal:  J Minim Invasive Gynecol       Date:  2020-01-09       Impact factor: 4.137

2.  Risk Factors for Endometriosis in a German Case-Control Study.

Authors:  S Burghaus; P Klingsiek; P A Fasching; A Engel; L Häberle; P L Strissel; M Schmidt; K Jonas; J D Strehl; A Hartmann; J Lermann; A Boosz; F C Thiel; A Müller; M W Beckmann; S P Renner
Journal:  Geburtshilfe Frauenheilkd       Date:  2011-12       Impact factor: 2.915

3.  Endometrial cells contribute to preexisting endometriosis lesions in a mouse model of retrograde menstruation†.

Authors:  Aya Tal; Reshef Tal; Nicola Pluchino; Hugh S Taylor
Journal:  Biol Reprod       Date:  2019-06-01       Impact factor: 4.285

Review 4.  Clinical diagnosis of pelvic endometriosis: a scoping review.

Authors:  Hedyeh Riazi; Najmeh Tehranian; Saeideh Ziaei; Easa Mohammadi; Ebrahim Hajizadeh; Ali Montazeri
Journal:  BMC Womens Health       Date:  2015-05-08       Impact factor: 2.809

Review 5.  Tobacco smoking and risk of endometriosis: a systematic review and meta-analysis.

Authors:  Francesca Bravi; Fabio Parazzini; Sonia Cipriani; Francesca Chiaffarino; Elena Ricci; Vito Chiantera; Paola Viganò; Carlo La Vecchia
Journal:  BMJ Open       Date:  2014-12-22       Impact factor: 2.692

6.  Role of vascular endothelial growth factor polymorphisms (-2578C>A, -460 T>C, -1154G>A, +405G>C and +936C>T) in endometriosis: a case-control study with Brazilians.

Authors:  Jamila Alessandra Perini; Jessica Vilarinho Cardoso; Plínio Tostes Berardo; Rosane Vianna-Jorge; Luiz Eurico Nasciutti; Marta Bellodi-Privato; Daniel Escorsim Machado; Mauricio Simões Abrão
Journal:  BMC Womens Health       Date:  2014-09-26       Impact factor: 2.809

7.  Factors associated with deep infiltrating endometriosis versus ovarian endometrioma in China: a subgroup analysis from the FEELING study.

Authors:  Yi Dai; Yingfang Zhou; Xinmei Zhang; Min Xue; Pengran Sun; Jinhua Leng; Charles Chapron
Journal:  BMC Womens Health       Date:  2018-12-22       Impact factor: 2.809

Review 8.  Ovarian hormones-autophagy-immunity axis in menstruation and endometriosis.

Authors:  Hui-Hui Shen; Tao Zhang; Hui-Li Yang; Zhen-Zhen Lai; Wen-Jie Zhou; Jie Mei; Jia-Wei Shi; Rui Zhu; Feng-Yuan Xu; Da-Jin Li; Jiang-Feng Ye; Ming-Qing Li
Journal:  Theranostics       Date:  2021-01-19       Impact factor: 11.556

9.  Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients.

Authors:  Mauricio S Abrao; Eric Surrey; Keith Gordon; Michael C Snabes; Hui Wang; Horia Ijacu; Hugh S Taylor
Journal:  BMC Womens Health       Date:  2021-06-16       Impact factor: 2.809

10.  Length of Menstrual Cycle and Risk of Endometriosis: A Meta-Analysis of 11 Case-Control Studies.

Authors:  Ming Wei; Yanfei Cheng; Huaien Bu; Ye Zhao; Wenli Zhao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.